Celtic's Big Top Off

Celtic Therapeutics expects a final close before year end for a new fund targeting $700 million, co-founder and Managing General Partner Stephen Evans-Freke told Ebb & Flow. Last week, Celtic disclosed what will be its fourth acquisition from the fund.

The fund had a first close over $100 million at the end of 2008 and went out to raise more money in June with Morgan Stanley...